Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hugh R Barrett

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|February 13, 2010
Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesityDick C Chan, Gerald F Watts, SengKhee Gan, et al.
Clinical Biochemistry|July 5, 2005
Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight menDick C Chan, Gerald F Watts, Theodore W K Ng, et al.
Heart, Lung & Circulation|December 27, 2015
Plasma Proprotein Convertase Subtilisin Kexin Type 9 as a Predictor of Carotid Atherosclerosis in Asymptomatic AdultsDick C Chan, Jing Pang, B M McQuillan, et al.
Medicine and Science in Sports and Exercise|December 15, 2017
Acute Impact of Different Exercise Modalities on Arterial and Platelet FunctionAndrew Haynes, Matthew D Linden, Elisa Robey, et al.
Metabolism: Clinical and Experimental|May 10, 2011
Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese menDick C Chan, Gerald F Watts, Esther M M Ooi, et al.
Journal of Lipid Research|October 29, 2002
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycanKatherine Olin-Lewis, Ronald M Krauss, Michael La Belle, et al.
Circulation|December 13, 2016
Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein MetabolismGerald F Watts, Dick C Chan, Ricardo Dent, et al.
Metabolism: Clinical and Experimental|February 26, 2003
Effect of weight loss on postprandial lipemia and low-density lipoprotein receptor binding in overweight menAnthony P James, Gerald F Watts, P Hugh R Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2015
Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin TreatmentTheodore W K Ng, Esther M M Ooi, Gerald F Watts, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2012
Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol effluxDick C Chan, Anh Hoang, P Hugh R Barrett, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Arteriosclerosis, Thrombosis, and Vascular Biology|February 13, 2010
Nonalcoholic fatty liver disease as the transducer of hepatic oversecretion of very-low-density lipoprotein-apolipoprotein B-100 in obesityDick C Chan, Gerald F Watts, SengKhee Gan, et al.
Clinical Biochemistry|July 5, 2005
Apolipoprotein B-100 kinetics and static plasma indices of triglyceride-rich lipoprotein metabolism in overweight menDick C Chan, Gerald F Watts, Theodore W K Ng, et al.
Heart, Lung & Circulation|December 27, 2015
Plasma Proprotein Convertase Subtilisin Kexin Type 9 as a Predictor of Carotid Atherosclerosis in Asymptomatic AdultsDick C Chan, Jing Pang, B M McQuillan, et al.
Medicine and Science in Sports and Exercise|December 15, 2017
Acute Impact of Different Exercise Modalities on Arterial and Platelet FunctionAndrew Haynes, Matthew D Linden, Elisa Robey, et al.
Metabolism: Clinical and Experimental|May 10, 2011
Apolipoprotein A-II and adiponectin as determinants of very low-density lipoprotein apolipoprotein B-100 metabolism in nonobese menDick C Chan, Gerald F Watts, Esther M M Ooi, et al.
Journal of Lipid Research|October 29, 2002
ApoC-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycanKatherine Olin-Lewis, Ronald M Krauss, Michael La Belle, et al.
Circulation|December 13, 2016
Factorial Effects of Evolocumab and Atorvastatin on Lipoprotein MetabolismGerald F Watts, Dick C Chan, Ricardo Dent, et al.
Metabolism: Clinical and Experimental|February 26, 2003
Effect of weight loss on postprandial lipemia and low-density lipoprotein receptor binding in overweight menAnthony P James, Gerald F Watts, P Hugh R Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2015
Association of Plasma Ceramides and Sphingomyelin With VLDL apoB-100 Fractional Catabolic Rate Before and After Rosuvastatin TreatmentTheodore W K Ng, Esther M M Ooi, Gerald F Watts, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2012
Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol effluxDick C Chan, Anh Hoang, P Hugh R Barrett, et al.
Pageof 15